BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35633639)

  • 1. A Novel Heterozygous
    Qin S; Zhang Y; Yu F; Ni Y; Zhong J
    J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):438-443. PubMed ID: 35633639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1-58 deletion: a case report.
    Zhang Z; Chen X; Zhou R; Yin H; Xu J
    BMC Pediatr; 2020 May; 20(1):190. PubMed ID: 32357851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.
    Vurallı D; Gönç N; Vidaud D; Özön A; Alikaşifoğlu A; Kandemir N
    J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):96-100. PubMed ID: 26758488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
    Long X; Xiong J; Mo Z; Zhang Q; Jin P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Neurofibromatosis Noonan Syndrome Patient Presenting with Abnormal External Genitalia.
    Işık E; Onay H; Atik T; Solmaz AE; Özen S; Çoğulu Ö; Darcan Ş; Özkınay F
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):113-116. PubMed ID: 31088041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene.
    Dalili S; Hoseini Nouri SA; Bayat R; Koohmanaee S; Tabrizi M; Zarkesh M; Tarang A; Mahdieh N
    Hum Genomics; 2023 Feb; 17(1):12. PubMed ID: 36803953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
    Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
    Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ullrich-Turner syndrome and neurofibromatosis-1.
    Schorry EK; Lovell AM; Milatovich A; Saal HM
    Am J Med Genet; 1996 Dec; 66(4):423-5. PubMed ID: 8989459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).
    Baralle D; Mattocks C; Kalidas K; Elmslie F; Whittaker J; Lees M; Ragge N; Patton MA; Winter RM; ffrench-Constant C
    Am J Med Genet A; 2003 May; 119A(1):1-8. PubMed ID: 12707950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
    Yao R; Wang L; Yu Y; Wang J; Shen Y
    J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new nonsense mutation in the NF1 gene with neurofibromatosis-Noonan syndrome phenotype.
    Yimenicioğlu S; Yakut A; Karaer K; Zenker M; Ekici A; Carman KB
    Childs Nerv Syst; 2012 Dec; 28(12):2181-3. PubMed ID: 22965773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1.
    Kyritsi EM; Hasiotou M; Kanaka-Gantenbein C
    Endocrine; 2020 Aug; 69(2):377-385. PubMed ID: 32519328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legius Syndrome and its Relationship with Neurofibromatosis Type 1.
    Denayer E; Legius E
    Acta Derm Venereol; 2020 Mar; 100(7):adv00093. PubMed ID: 32147744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
    Stevenson DA; Viskochil DH; Rope AF; Carey JC
    Clin Genet; 2006 Mar; 69(3):246-53. PubMed ID: 16542390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
    Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
    Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.